Mood and anxiety disorders Pre-clinical and mechanistic studies Articles relevant to this section mainly addressed depressive and anxiety conditions, while only two pre-clinical studies investigated the effect of GLP-1RAs in bipolar disorder (Supplementary Section 5)
Therefore, it is suggestive that there are definite benefits for overweight and obese individuals to increase their intake of leucine and/or total protein as a means for appetite and weight control
Gastrointestinal histology
Exosomes in osteoarthritis: breakthrough innovations and advanced tissue engineering for cartilage regeneration since 2020
The mean BMI was approximately 27.6 kg/m
Cagrilintide and Cagrilintide+Semagludite The amylin analog cagrilintide, which is still in clinical development, has demonstrated efficacy in metabolic diseases [17], [18] and may represent an alternative to GLP1-RA-based monotherapy in overweight and obesity alone or in combination with the GLP-1RA based treatment such as cagrilintide and semaglutide (CagriSema), to achieve sustained weight loss